Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015
Aeron C Hurt, Terry G Besselaar, Rod S Daniels, Burcu Ermetal, Alicia Fry, Larisa Gubareva, Weijuan Huang, Angie Lackenby, Raphael TC Lee, Janice Lo, Sebastian Maurer-Stroh, Ha T Nguyen, Dmitriy Pereyaslov, Helena Rebelo-de-Andrade, Marilda M Siqueira, Emi Takashita, Masato Tashiro, Danielle Tilmanis, Dayan Wang, Wenqing Zhang Show all
Antiviral Research | ELSEVIER | Published : 2016
Awarded by British Medical Research Council
Awarded by JSPS KAKENHI Grant
Awarded by joint A*STAR-NHMRC grant
We thank all laboratories, mostly NICs of the WHO GISRS (http://www.who.int/influenza/gisrs_laboratory/national_influenza_centres/list/en/), who contributed to this global analysis by submitting influenza virus positive samples (clinical specimens or virus isolates) to WHO CCs for detailed characterisation. We gratefully acknowledge the authors, originating and submitting laboratories of the 2440 sequences downloaded from the GISAID and NCBI-IVR databases, that were additional to those submitted by the authors of this paper. The London WHO CC is funded by the British Medical Research Council through programme U117512723. The Melbourne WHO CC is supported by the Australian Government, Department of Health. The Tokyo WHO CC is supported by Grants-in-Aid for Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour and Welfare, Japan and by JSPS KAKENHI Grant number 26460816. RTCL and SMS are supported by a joint A*STAR-NHMRC grant (#12/1/06/24/5793).